(secondQuint)Study to Observe the Effect of Mirapex ER Once-daily (QD) Versus Twice-daily (BID).

 1.

 Study subjects : Parkinson disease who are on Requip or Mirapex and are considering to change into Mirapex ER 2.

 Cross over study design: - Group 1: Once daily dose for 2 month then into BID in divided dose for 2 months - Group 2: BID in divided dose for 2 months then into QD dose for 2 months 3.

 Dose adjustment may be done in the first 4 weeks.

 4.

 Compare the benefit, side effects, and patient preference between the QD vs BID dosing.

 Study to Observe the Effect of Mirapex ER Once-daily (QD) Versus Twice-daily (BID)@highlight

1.

 In order to observe the benefit, side effects, and patient preference of Mirapex ER when used in once-daily (QD) or twice-daily (BID) dosing 2.

 In order to estimate the conversion rate of dopamine agonists into Mirapex ER